Cohort profile: the TrueNTH Global Registry - an international registry to monitor and improve localised prostate cancer health outcomes
نویسندگان
چکیده
PURPOSE Globally, prostate cancer treatment and outcomes for men vary according to where they live, their race and the care they receive. The TrueNTH Global Registry project was established as an international registry monitoring care provided to men with localised prostate cancer (CaP). PARTICIPANTS Sites with existing CaP databases in Movember fundraising countries were invited to participate in the international registry. In total, 25 Local Data Centres (LDCs) representing 113 participating sites across 13 countries have nominated to contribute to the project. It will collect a dataset based on the International Consortium for Health Outcome Measures (ICHOM) standardised dataset for localised CaP. FINDINGS TO DATE A governance strategy has been developed to oversee registry operation, including transmission of reversibly anonymised data. LDCs are represented on the Project Steering Committee, reporting to an Executive Committee. A Project Coordination Centre and Data Coordination Centre (DCC) have been established. A project was undertaken to compare existing datasets, understand capacity at project commencement (baseline) to collect the ICHOM dataset and assist in determining the final data dictionary. 21/25 LDCs provided data dictionaries for review. Some ICHOM data fields were well collected (diagnosis, treatment start dates) and others poorly collected (complications, comorbidities). 17/94 (18%) ICHOM data fields were relegated to non-mandatory fields due to poor capture by most existing registries. Participating sites will transmit data through a web interface biannually to the DCC. FUTURE PLANS Recruitment to the TrueNTH Global Registry-PCOR project will commence in late 2017 with sites progressively contributing reversibly anonymised data following ethical review in local regions. Researchers will have capacity to source deidentified data after the establishment phase. Quality indicators are to be established through a modified Delphi approach in later 2017, and it is anticipated that reports on performance against quality indicators will be provided to LDCs.
منابع مشابه
نظام ثبت سرطان بیمارستانی در ایران و مقایسه آن با آمریکا
Introduction: Cancer research is one of the essential activities for its control and treatment. Hospital based cancer registry system is an information system designed to collect, organize and analyze data on cancer. The objective of the present study was to compare hospital based cancer registry system in Iran with that in the USA. Methods: This research was a comparative study. Studied popul...
متن کاملTrend of Breast Cancer Incidence in Iran During A Fifteen-Year Interval According To National Cancer Registry Reports
Introduction: Breast cancer is the most common cancer and cause of cancer-related death in women. Recent years have witnessed dramatic changes in the incidence and mortality rates of breast cancer. Therefore, this study aimed to provide a report of breast cancer incidence trends between 2003 and 2017. Methods: This cross-sectional study examined Iran’s cancer registry reports from 2003 to 2017...
متن کاملDoes ethnicity affect survival following colorectal cancer? A prospective, cohort study using Iranian cancer registry
Background:The present study compared the differences between survivals of patients with colorectal cancer according to their ethnicity adjusted for other predictors of survival. Methods: In this prospective cohort study patients were followed up from definite diagnosis of colorectal cancer to death. Totally, 2431 person-year follow-ups were undertaken for 1127 colorectal cancer patients on...
متن کاملPatients with Localised Prostate Cancer (T1 - T2) Show Improved Overall Long-Term Survival Compared to the Normal Population
BACKGROUND Little information is available on the long-term outcomes of patients with localised prostate cancer. OBJECTIVE To examine the long-term survival of patients with localised prostate gland carcinoma T1 - T2, N0, M0 (UICC stage I and II) compared to the normal population. DESIGN Retrospective cohort. SETTING Regensburg, Germany. PARTICIPANTS Data on 2121 patients with histologi...
متن کاملQuality of life three years after diagnosis of localised prostate cancer: population based cohort study
OBJECTIVE To quantify the risk and severity of negative effects of treatment for localised prostate cancer on long term quality of life. DESIGN Population based, prospective cohort study with follow-up over three years. SETTING New South Wales, Australia. PARTICIPANTS Men with localised prostate cancer were eligible if aged less than 70 years, diagnosed between October 2000 and October 20...
متن کامل